The foundation that controls Danish drugmaker Novo Nordisk said on Monday it is in preliminary talks with the government about establishing local COVID-19 vaccine production.
“We can confirm that we have discussions with the government about the possibilities of establishing a vaccine production in Denmark,” said Steffen Luders, senior vice president of the Novo Nordisk Foundation, without elaborating.
Business Minister Simon Kollerup confirmed in an email that the government is in talks with the country’s life science industry, including the foundation.
The news, first reported by Berlingske newspaper, comes after Danish Prime Minister Mette Frederiksen openly expressed concern over delays in the European Union in ordering, approving and distributing COVID-19 vaccines.
This month she travelled to Israel for talks with Prime Minister Benjamin Netanyahu Austrian Chancellor Sebastian Kurz about possible joint production facilities for COVID-19 vaccines.
The Novo Nordisk Foundation, which at the end of 2019 had a total net worth of 411 billion Danish crowns ($66 billion), focuses on medical treatment and research through grants and its controlling stakes in Novo Nordisk and Novozymes.
WHO says effective controls in place as nations pause AstraZeneca shotsWorld Health Organization Director General Tedros Adhanom Ghebreyesus said systems meant to protect public health were working, as several countries ... Coronavirus
Denmark halts AstraZeneca vaccine due to serious cases of blood clotsDenmark has temporarily suspended AstraZeneca COVID-19 vaccine shots after reports of cases of blood clots forming, including one in Denmark, Danish ... Coronavirus
Indonesia halts COVID-19 vaccinations with AstraZeneca, awaits WHO reviewIndonesia will delay the administering of AstraZeneca’s COVID-19 vaccine due to reports of blood clots among some recipients in Europe and would await ... Coronavirus
Future battle with COVID-19 virus to include regular booster vaccinations: ExpertRegular booster vaccines against the novel coronavirus will be needed because of mutations that make it more transmissible and better able to evade ... Coronavirus